Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

UB VV200

Next Previous
Drug Profile

UB VV200

Alternative Names: UB VV200 + TumorTag cocktail - Umoja Biopharma; UB VV200 with TumorTag cocktail - Umoja Biopharma; UBVV200

Latest Information Update: 28 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Umoja Biopharma
  • Class Antineoplastics; CAR-T cell therapies; Gene therapies; Immunotherapies
  • Mechanism of Action Cytotoxic T lymphocyte stimulants; Immunologic cytotoxicity; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Osteosarcoma

Most Recent Events

  • 28 Jun 2025 No recent reports of development identified for phase-I development in Osteosarcoma(In adolescents, In children, Recurrent, Second-line therapy or greater, In adults) in USA (Parenteral)
  • 17 May 2023 Pharmacodynamics data from preclinical trial in solid tumours released by Umoja Biopharma
  • 06 Apr 2023 Umoja plans to file IND application for UB VV200 along with additional Tags for Solid tumour in 2024 (Umoja pipeline, April 2023)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top